SEGLUROMET 500 mg/1 (Ertugliflozin and Metformin Hydrochloride TABLET, FILM COATED) 500 mg/1

Segluromet 500 mg/1 combines ertugliflozin and metformin hydrochloride for managing type 2 diabetes. This oral medication supports blood sugar control as part of a broader treatment plan.

Strength

500 mg/1

Pack Size

60 TABLET, FILM COATED in 1 BOTTLE (0006-5370-03)

Manufacturer / TM Owner

Merck Sharp & Dohme LLC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Segluromet 500 mg/1 is typically used to improve glycemic control in adults with type 2 diabetes. It works by combining two active ingredients: ertugliflozin, which helps the kidneys remove excess glucose, and metformin, which reduces glucose production in the liver. This combination is often part of a comprehensive diabetes management strategy that includes diet and exercise.

Side Effects

Common effects of Segluromet 500 mg/1 may include gastrointestinal discomfort, such as nausea or diarrhea, particularly when starting treatment. Some users may also experience urinary tract infections or low blood sugar levels, especially when combined with other diabetes medications. These effects vary and are not experienced by everyone.

Precautions & Warnings

Segluromet 500 mg/1 should be used with caution in individuals with kidney issues or those at risk of lactic acidosis. It is important to stay hydrated and monitor kidney function regularly. Always consult a healthcare provider before starting or adjusting any medication.

Avoid Interactions

Segluromet 500 mg/1 may interact with certain medications, including diuretics, ACE inhibitors, and other diabetes treatments. Alcohol can increase the risk of lactic acidosis, so it should be avoided. Always inform your healthcare provider about all medications you are taking to avoid potential interactions.

Frequently Asked Questions

Segluromet 500 mg/1 is used to manage type 2 diabetes by improving blood sugar control.

Segluromet 500 mg/1 is taken orally, typically once or twice daily, as directed by a healthcare provider.

Common side effects may include gastrointestinal discomfort, urinary tract infections, and low blood sugar levels.

Segluromet 500 mg/1 may interact with certain medications, so it is important to consult a healthcare provider before combining it with other treatments.

Segluromet 500 mg/1 should be used with caution in individuals with kidney issues or those at risk of lactic acidosis.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.